October 20, 2021
October 20, 2021 – The U.S. FDA has amended the emergency use authorizations (EUAs) for COVID-19
vaccines to expand the use of booster shots in eligible individuals
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
Global Reach Health News
October 20, 2021
October 20, 2021 – Vimpat® (lacosamide – UCB, Inc.) has been approved to treat partial-onset seizures in patients who are at least one month old. This indication was previously
October 20, 2021
October 20, 2021 – Dupixent® (dupilumab) can now be used to treat asthma in a wider age group, as the U.S. FDA has expanded its asthma indication to include children ages
October 19, 2021
October 19, 2021 – Merck has recalled one lot of Cubicin® (daptomycin for injection) 500mg for intravenous (IV) infusion, following a customer complaint that a piece
October 18, 2021
October 18, 2021 – Gilead's Biktarvy® (bictegravir/emtricitabine/tenofovir alafenamide) has received an
expanded indication to treat HIV-1 in children who weigh 14kg
October 18, 2021
October 18, 2021 – TyrvayaTM (varenicline solution – Oyster Pharma) nasal spray 0.03mg has received U.S. FDA approval to treat the signs and symptoms
October 18, 2021
October 18, 2021 – Esteve Pharmaceuticals has received U.S. FDA approval for Seglentis® (celecoxib/tramadol hydrochloride) to manage acute pain in adults that is severe
October 18, 2021
October 18, 2021 – The U.S. FDA has approved ZimhiTM (naloxone HCl) 5mg/0.5mL, a high-dose naloxone injection, to treat opioid overdoses.